ABSTRACT:
The objective of this work was to precisely design novel lipid composition and investigate for improved characteristics to enhance the bioavailability of isoniazid (INH) loaded in nanostructured lipid carrier (NLC). Response surface methodology (RSM)-Central composite rotatable design (CCRD) was used to evaluate the effect of formulation variables, the ratio of two different solid lipids, solid lipid: liquid lipid, and the drug concentration on response variables. The encapsulation efficiency (EE) of optimized formulation was found to be 72.82±0.49%, drug loading (DL) was 15.15±0.10%, mean particle size (PS) was 285.1±4.71nm and in vitro drug release (DR) was 75.30±1.95% in 24 h. The optimized formulation was investigated via Differential Scanning Calorimetry (DSC), X-Ray Diffraction Pattern (XRD) analysis, in vitro release kinetics and Transmission electron microscopy (TEM). The polydispersity index (PDI) and zeta potential (ZP) were determined as 0.484±0.026 and +21±1.44mV respectively. Formulations were found to be most stable up to 25°C for 6 months. The present study successfully optimized the lipid combination at different concentrations and introduced the best composition of lipids with improved characteristics of INH-NLC formulation and expected to increase the bioavailability of isoniazid to replace the conventional drug delivery system for tuberculosis.
Cite this article:
Shaveta Ahalwat, D. C. Bhatt, Surbhi Rohilla. Fabrication of Lipid Combination for Bioavailability Enhancement of Isoniazid. Research Journal of Pharmacy and Technology 2022; 15(12):5589-6. doi: 10.52711/0974-360X.2022.00944
Cite(Electronic):
Shaveta Ahalwat, D. C. Bhatt, Surbhi Rohilla. Fabrication of Lipid Combination for Bioavailability Enhancement of Isoniazid. Research Journal of Pharmacy and Technology 2022; 15(12):5589-6. doi: 10.52711/0974-360X.2022.00944 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-12-38
REFERENCES:
1. Murray JF, Schraufnagel DE, Hopewell PC. Treatment of tuberculosis. A historical perspective. Annals of the American Thoracic Society. 2015;12(12):1749-1759. https://doi.org/10.1513/AnnalsATS.201509-632PS
2. Pandit S, Roy S, Pillai J, Banerjee S. Formulation and intracellular trafficking of lipid–drug conjugate nanoparticles containing a hydrophilic antitubercular drug for improved intracellular delivery to human macrophages. ACS Omega. 2020;5(9):4433-4448. https://doi.org/10.1021/acsomega.9b03523.
3. Schroeder EK, Desouza ON, Santos DS, Blanchard JS, Basso LA. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Current Pharmaceutical Biotechnology. 2002;3(3):197-225. https://doi.org/10.2174/13892010233783288.
4. Rastogi R, Sultana Y, Aqil M, Ali A, Kumar S, Chuttani K, Mishra AK. Alginate microspheres of isoniazid for oral controlled drug delivery. International Journal of Pharmaceutics. 2007;334(1-2):71-77. https://doi.org/10.1016/j.ijpharm.2006.10.024
5. Singh M, Guzman-Aranguez A, Hussain A, Srinivas CS, Kaur IP. Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics. Nanomedicine. 2019;14(4):465-491. https://doi.org/10.2217/nnm-2018-0278
6. He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W. Adapting liposomes for oral drug delivery. Acta Pharmaceutica Sinica B. 2019;9(1):36-48. https://doi.org/10.1016/j.apsb.2018.06.005
7. Bansal S, Aggarwal G, Chandel P, Harikumar SL. Design and development of cefdinir niosomes for oral delivery. Journal of Pharmacy & Bioallied Sciences. 2013;5(4):318. https://doi.org/10.4103/0975-7406.120080
8. Sabjan KB, Munawar SM, Rajendiran D, Vinoji SK, Kasinathan K. Nanoemulsion as Oral Drug Delivery-A Review. Current Drug Research Reviews. 2020;12(1):4-15. https://doi.org/10.2174/2589977511666191024173508
9. Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855. https://doi.org/10.3390/pharmaceutics12090855
10. Basha SK, Dhandayuthabani R, Muzammil MS, Kumari VS. Solid lipid nanoparticles for oral drug delivery. Materials Today: Proceedings. 2021;36:313-324. https://doi.org/10.1016/j.matpr.2020.04.109
11. Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25(9):2193. https://doi.org/10.3390/molecules25092193
12. Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W, Shi Y. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technology. 2010;197(1-2):120-128. https://doi.org/10.1016/j.powtec.2009.09.004
13. Velmurugan R, Selvamuthukumar S. Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology. Applied Nanoscience. 2016;6(2):159-173. https://doi.org/10.1007/s13204-015-0434-6
14. Sharma A, Baldi A. Nanostructured lipid carriers: A review. Journal of Developing Drugs. 2018;7(2):191-203. https://doi.org/10.4172/2329-6631.1000191
15. Shenoy VS, Rajyaguru TH, Gude RP, Murthy RSR. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles. Journal of Microencapsulation. 2019;26(6):471-478. https://doi.org/10.1080/02652040802379902
16. Ghule MM, Bhoyar GS. Formulation and Evaluation of modified liposome for transdermal drug. Journal of Developing Drugs. 2018;7(1):2-3. https://doi.org/10.4172/2329-6631.1000186
17. El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. International Journal of Pharmaceutics. 2006;308(1-2):140-148. https://doi.org/10.1016/j.ijpharm.2005.11.006
18. Lee JS, Song YB, Lee JY, Kim MK, Jun SJ, Lee HG. Optimization and oxidative stability of the microencapsulated conjugated linoleic acid. International Journal of Biological Macromolecules. 2009;45(4):348-351. https://doi.org/10.1016/j.ijbiomac.2009.07.012
19. Kumar P, Tiwari A, Chhabra G, Pathak K. Use of central composite design for statistical optimization promethazine theoclate-loaded solid lipid nanoparticles. Asian Journal of Pharmaceutics. 2014;8(4):279-286. https://doi.org/10.4103/0973-8398.143945
20. Yang G, Wu F, Chen M, Jin J, Wang R, Yuan Y. Formulation design, characterization and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. International Journal of Nanomedicine. 2019;14:2267. https://doi.org/10.2147/IJN.S194934
21. Nemati E, Mokhtarzadeh A, Panahi-Azar V, Mohammadi A, Hamishehkar H, Mesgari-Abbasi M, De la Guardia, M. Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy. AAPS Pharmaceutical Science and Technology. 2019;20(3):1-9. https://doi.org/10.1208/s12249-019-1334-y
22. Duong VA, Maeng HJ, Chi SC. Nanostructured lipid carriers containing ondansetron hydrochloride by cold high-pressure homogenization method: Preparation, characterization and pharmacokinetic evaluation. Journal of Drug Delivery Science and Technology. 2019;53:101185. https://doi.org/10.1016/j.jddst.2019.101185
23. Sreedevi G, Manasa L, Divya B, Kumari S, Sai S. Eco-friendly Synthesis of Silver Nanoparticles using seeds of Sorghum bicolor. Research Journal of Pharmacy and Technology. 2020;13(12):5935-5938. https://doi.org/10.5958/0974-360X.2020.01036.7
24. Choudhary UM, Mistree RY, Patel DN, Desai SV, Patoliya NA, Shah CN, Upadhyay U. Formulation and Development of Aceclofenac loaded Microsponges Topical Drug Delivery System using quality by Design Approach. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):185-2. https://doi.org/10.52711/0975-4377.2021.00033
25. Sudha Rameshwari K, Abirami M, Gloria Jemmi Christobel R. Partial Characterization of green synthesized silver nanoparticles of Cardiospermum halicacabum and Butea monosperma aqueous extract combination (CHBMCSNP). Research Journal of Pharmacy and Technology. 2020;13(12):6218-6223. https://doi.org/10.5958/0974-360X.2020.01084.7
26. Kumar PP, Nayak MR, Srinivasa Rao A. Formulation Design and In-vitro Characterization of Docetaxel Cubosomes for Gastric Cancer therapy. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):179-4. https://doi.org/10.52711/0975-4377.2021.00032
27. Wu PS, Lin CH, Kuo YC, Lin CC. Formulation and characterization of hydroquinone nanostructured lipid carriers by homogenization emulsification method. Journal of Nanomaterials. 2017:3282693. https://doi.org/10.1155/2017/3282693
28. Shinde S, Yadav V, Jadhav P, Jadhav A. Formulation and Evaluation of Microemulsion containing Anti-Hypertensive Drug. Research Journal of Pharmacy and Technology. 2020;13(12):5726-5732. https://doi.org/10.5958/0974-360X.2020.00997.X
29. Shah NV, Seth AK, Balaraman R, Aundhia CJ, Maheshwari RA, Parmar GR. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. Journal of Advanced Research. 2016;7(3):423-434. https://doi.org/10.1016/j.jare.2016.03.002
30. Velivela S, Pati NB, Babu BR. Formulation development of Temozolomide liposomal formulation in the treatment of Glioma. Asian Journal of Pharmacy and Technology. 2021;11(3):203-6. https://doi.org/10.52711/2231-5713.2021.00033
31. Kresnawati Y, Shantiningsih RR, Martien R. Optimization of Soybean Oil, Tween 80, PEG 400 in Formulation of Beta Carotene Nanoemulsion. Research Journal of Pharmacy and Technology. 2020;13(12):5692-5698. https://doi.org/10.5958/0974-360X.2020.00991.9
32. Chandrasekhar RB, Krishnaveni B, Krishna Mohan G, Jithan AV. Preparation, Characterization and In Vivo Evaluation of Dexamethasone Nanoparticles for the treatment of Liver Fibrosis. Research Journal of Pharmacy and Technology. 2020;13(12):6098-6104. https://doi.org/10.5958/0974-360X.2020.01063.X
33. Kumara SS, Agaiah GB, Satla SR, Mahendra Kumar CB. Effect of various Polymers on Drug Release from Mucoadhesive Tablets of Cefixime Trihydrate. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):167-3. https://doi.org/10.52711/0975-4377.2021.00030
34. Yadav C, Mohammad A, Akhtar J, Badruddeen, Mohammad IK, Saquib, Tanweer, Mohammad A, Laiba R. An outline on Curcumin: Its pro-liposome and Liposome Formulations. Research Journal of Pharmacy and Technology. 2020;13(12):6276-6283. https://doi.org/10.5958/0974-360X.2020.01092.6
35. Sarangi D, Mallick S, Ara A, Sahoo SK, Rana R. An Assessment of Olmesartan Medoxomil Tablet by Inclusion Complex Technique. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):193-7. https://doi.org/10.52711/0975-4377.2021.00034
36. Thummala UK, Maddi EG, Avula PR. Optimization and development of orodispersible films for ledipasvir and sofosbuvir through solid dispersion using Box-Behnken design. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021;13(3):201-8. https://doi.org/10.52711/0975-4377.2021.00036
37. Han L, Wang T. Preparation of glycerol monostearate from glycerol carbonate and stearic acid. RSC Advances. 2016;6(41):34137-34145. https://doi.org/10.1039/C6RA02912D
38. Baruah UK, Gowthamarajan K, Ravisankar V, Karri VVSR, Simhadri PK, Singh V, Babu PP. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate. Artificial Cells, Nanomedicine and Biotechnology. 2016;46(8):1809-1829. https://doi.org/10.1080/21691401.2017.1394870
39. Abdullah BM, Salih N, Salimon J. Optimization of the chemoenzymatic mono-epoxidation of linoleic acid using D-optimal design. Journal of Saudis Chemical Society. 2014;18(3):276-287. https://doi.org/10.1016/j.jscs.2011.07.012
40. Afinjuomo F, Barclay TG, Parikh A, Chung R, Song Y, Nagalingam G, Garg S. Synthesis and characterization of pH-sensitive inulin conjugate of isoniazid for monocyte-targeted delivery. Pharmaceutics. 2019;11(11):555. https://doi.org/10.3390/pharmaceutics11110555
41. Haddadin R, Qian F, Desikan S, Hussain M, Smith RL. Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation. Pharmaceutical development and technology. 2009;14(1):19-27. https://doi.org/10.1080/10837450802409370
42. Gardouh AR, Gad S, Ghonaim HM, Ghorab MM. Design and characterization of glyceryl monostearate solid lipid nanoparticles prepared by high shear homogenization. Journal of Pharmaceutical Research International. 2013:326-346. https://doi.org/10.9734/BJPR/2013/2770
43. Zidan AS, Spinks C, Fortunak J, Habib M, Khan MA. Near-infrared investigations of novel anti-HIV tenofovir liposomes. The AAPS Journal. 2010;12(2):202-214. https://doi.org/10.1208/s12248-010-9177-1
44. Rohilla S, Bhatt DC, Ahalwat S. Fabrication of potential gastroretentive microspheres of itraconazole for stomach-specific delivery: Statistical optimization and in vitro evaluation. Journal of Applied Pharmaceutical Science. 2020;10(03):119-127. https://doi.org/10.7324/JAPS.2020.103016
45. Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Advanced Pharmaceutical Bulletin. 2020;10(2):150. https://doi.org/10.34172/apb.2020.021
46. Caputo F, Clogston J, Calzolai L, Rosslein M, Prina-Mello A. Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step-by-step approach combining orthogonal measurements with increasing complexity. Journal of Controlled Release. 2019;299:31-43. https://doi.org/10.1016/j.jconrel.2019.02.030
47. Ashraf MA, Peng W, Zare Y, Rhee KY. Effects of size and aggregation/agglomeration of nanoparticles on the interfacial/interphase properties and tensile strength of polymer nanocomposites. Nanoscale research letters. 2018;13(1):1-7. https://doi.org/10.1186/s11671-018-2624-0
48. Wang N, Cheng X, Li N, Wang H, Chen H. Nanocarriers and their loading strategies. Advanced Healthcare Materials. 2019;8(6):1801002. https://doi.org/10.1002/adhm.201801002